BUBACCO, LUIGI
 Distribuzione geografica
Continente #
NA - Nord America 12.516
EU - Europa 1.167
AS - Asia 1.030
OC - Oceania 4
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 2
Totale 14.725
Nazione #
US - Stati Uniti d'America 12.507
CN - Cina 568
SG - Singapore 348
IT - Italia 302
FI - Finlandia 256
DE - Germania 140
UA - Ucraina 139
SE - Svezia 132
GB - Regno Unito 94
VN - Vietnam 64
FR - Francia 28
IN - India 24
IE - Irlanda 23
RU - Federazione Russa 12
ES - Italia 10
HK - Hong Kong 8
NL - Olanda 7
CA - Canada 5
KR - Corea 4
MX - Messico 4
TR - Turchia 4
AU - Australia 3
BE - Belgio 3
BG - Bulgaria 3
CZ - Repubblica Ceca 3
EU - Europa 3
IR - Iran 3
JP - Giappone 3
PL - Polonia 3
AT - Austria 2
DZ - Algeria 2
MK - Macedonia 2
NO - Norvegia 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CL - Cile 1
CO - Colombia 1
DK - Danimarca 1
EG - Egitto 1
HU - Ungheria 1
IL - Israele 1
NZ - Nuova Zelanda 1
RS - Serbia 1
TH - Thailandia 1
Totale 14.725
Città #
Fairfield 2.044
Woodbridge 1.535
Chandler 1.122
Ann Arbor 1.089
Houston 1.041
Ashburn 816
Wilmington 721
Seattle 690
Cambridge 631
Jacksonville 601
Princeton 290
Singapore 261
San Diego 213
Beijing 166
Padova 133
Nanjing 109
Medford 108
Helsinki 104
Boardman 103
Roxbury 102
Des Moines 100
Dong Ket 62
Santa Clara 48
Shenyang 33
Hebei 31
Nanchang 28
London 27
Dublin 22
Los Angeles 21
Norwalk 21
Guangzhou 20
Jiaxing 20
New York 20
Tappahannock 17
Falls Church 16
Hefei 15
Naples 15
Redwood City 14
Tianjin 14
Changsha 12
Phoenix 12
Kharkiv 11
Munich 11
Indiana 10
Jinan 10
Ogden 10
Zhengzhou 10
Chiswick 9
Kilburn 9
Milan 9
San Francisco 9
Hong Kong 8
Kunming 8
Lappeenranta 8
Rome 8
Borås 6
Venice 6
Hangzhou 5
Hounslow 5
Legnaro 5
Prescot 5
Chantada 4
Chicago 4
Delhi 4
Fort Worth 4
Gavirate 4
Orange 4
Perugia 4
Pompei 4
Rockville 4
Siheung-si 4
Treviso 4
Yenibosna 4
Acton 3
Amsterdam 3
Arzignano 3
Augusta 3
Chengdu 3
Dallas 3
Detroit 3
Fuzhou 3
Harbin 3
Livorno 3
Modena 3
Montefiascone 3
Málaga 3
Ningbo 3
Paris 3
Radomsko 3
Shanghai 3
Sofia 3
Sydney 3
Toronto 3
Verona 3
Washington 3
Aachen 2
Barneveld 2
Bologna 2
Bratislava 2
Buffalo 2
Totale 12.733
Nome #
LRRK2 phosphorylates pre-synaptic N-ethylmaleimide sensitive fusion (NSF) protein enhancing its ATPase activity and SNARE complex disassembling rate 169
The functional dissection of the plasma corona of SiO2-NPs spots histidine rich glycoprotein as a major player able to hamper nanoparticle capture by macrophages 166
Dopamine oxidation products as mitochondrial endotoxins, a potential molecular mechanism for preferential neurodegeneration in Parkinson Disease 158
Inhibition of the deubiquitinase USP8 corrects a Drosophila PINK1 model of mitochondria dysfunction 151
Superoxide Dismutases SOD1 and SOD2 Rescue the Toxic Effect of Dopamine-Derived Products in Human SH-SY5Y Neuroblastoma Cells. 139
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains 136
2-Hydroxypyridine-N-oxide-Embedded Aurones as Potent Human Tyrosinase Inhibitors 135
USP14 inhibition corrects an in vivo model of impaired mitophagy 134
Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice 133
Leucine-rich repeat kinase 2 controls protein kinase A activation state through phosphodiesterase 4 133
Superoxide Radical Dismutation as New Therapeutic Strategy in Parkinson’s Disease 125
A Topological Model of the Interaction between alpha-Synuclein and SDS Micelles. 123
2-Hydroxypyridine-N-oxide-Embedded Aurones as Potent Human Tyrosinase Inhibitors 122
Role of the tertiary structure in the diphenol oxidase activity of Octopus vulgaris hemocyanin 121
Human Tyrosinase Produced in Insect Cells: A Landmark for the Screening of New Drugs Addressing its Activity 121
Leucine-rich repeat kinase 2 and alpha-synuclein: intersecting pathways in the pathogenesis of Parkinson's disease? 121
Small molecules interacting with α-synuclein: antiaggregating and cytoprotective properties. 119
Determination of ATP, ADP, and AMP levels by reversed-phase high-performance liquid chromatography in cultured cells 118
Molecular evolution and phylogeny of sipunculan hemerythrins. 118
Nitrite reductase activity of deoxy Carcinus maenas hemocyanin: Formation of the half-met derivative 116
Dopamine-derived Quinones Affect the Structure of the Redox Sensor DJ-1 through Modifications at Cys-106 andCys-53 116
Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson’s disease 116
Molecular Basis of the Bohr Effect in Arthropod Hemocyanin 114
Conformational equilibria in monomeric alpha-synuclein at the single-molecule level 113
Anti-oxidants in Parkinson's disease therapy: a critical point of view 110
Structural Role of the Copper Ions in the Dinuclear Active Site of Carcinus aestuarii Hemocyanin 109
Transcriptome analysis of LRRK2 knock-out microglia cells reveals alterations of inflammatory- and oxidative stress-related pathways upon treatment with α-synuclein fibrils 109
Leucine-rich repeat kinase 2 positively regulates inflammation and down-regulates NF-κB p50 signaling in cultured microglia cells 108
Broken helix in vesicle and micelle-bound alpha-synuclein: Insights from site-directed spin labeling-EPR experiments and MD simulations 108
Observing the osmophobic effect in action at the single molecule level 108
Single-molecule-level evidence for the osmophobic effect. 106
Biochemical Characterization of Highly Purified Leucine-Rich Repeat Kinases 1 and 2 Demonstrates Formation of Homodimers 106
Type-3 copper proteins as biocompatible and reusable oxygen sensors 105
Recent findings on the physiological function of DJ-1: Beyond Parkinson's disease. 105
GTP binding regulates cellular localization of Parkinsońs disease-associated LRRK2 105
Ceramides in Parkinson's Disease: From Recent Evidence to New Hypotheses 105
Cobalt substituted derivatives of Carcinus hemocyanin. 104
Dysfunction of dopamine homeostasis: clues in the hunt for novel Parkinson’s disease therapies. 103
Are dopamine derivatives implicated in the pathogenesis of Parkinson's disease? 103
Tyrosinase-catalyzed Oxidation of Fluorophenols 102
LRRK2 kinase activity regulates synaptic vesicle trafficking and neurotransmitter release through modulation of LRRK2 macro-molecular complex 102
Triggering of Inflammasome by Aggregated α–Synuclein, an Inflammatory Response in Synucleinopathies 102
Covalent alfa-synuclein dimers: chemico-physical and aggregation properties 102
Structural insights on physiological functions and pathological effects of α-Synuclein 101
Human SOD2 Modification by Dopamine Quinones Affects Enzymatic Activity by Promoting Its Aggregation: Possible Implications for Parkinson's Disease. 101
What are the structural features of the active site that define binuclear copper proteins function? 100
DJ-1 is a copper chaperone acting on SOD1 activation. 100
DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function 99
Dopamine quinones interact with a-synuclein to form unstructured adducts 99
Human leucine-rich repeat kinase 1 and 2: intersecting or unrelated functions? 98
Analysis of the Catecholaminergic Phenotype in Human SH-SY5Y and BE(2)-M17 Neuroblastoma Cell Lines upon Differentiation 98
Structural and morphological characterization of aggregated species of {alpha}-synuclein induced by docosahexaenoic acid. 96
Isolation of the met-derivative intermediate in the catalase-like activity of deoxygenated Octopus vulgaris hemocyanin 96
Trapping tyrosinase key active intermediate under turnover 96
Leucine-rich repeat kinase 2 interacts with p21-activated kinase 6 to control neurite complexity in mammalian brain 96
THE AROMATIC CIRCULAR-DICHROISM SPECTRUM AS A PROBE FOR CONFORMATIONAL-CHANGES IN THE ACTIVE-SITE ENVIRONMENT OF HEMOCYANINS 95
CIRCULAR-DICHROISM AND FLUORESCENCE STUDIES TO PROBE THE CONFORMATIONAL PROPERTIES OF RHUS-VERNICIFERA LACCASE 95
Insights into the oligomerization process of the C-terminal domain of human plasma membrane Ca2+-ATPase 95
Parkinson's disease and immune system: is the culprit LRRKing in the periphery? 94
Diabetes Mellitus as a Risk Factor for Parkinson's Disease: a Molecular Point of View 94
The chaperone-like protein 14-3-3η interacts with human α-synuclein aggregation intermediates rerouting the amyloidogenic pathway and reducing α-synuclein cellular toxicity. 94
Molecular heterogeneity of the hemocyanin isolated from the king crab Paralithodes camtschaticae 93
STRUCTURAL CHARACTERIZATION OF MONONUCLEAR CU(II) AND ITS NITRITE COMPLEX IN THE ACTIVE-SITE OF CARCINUS-MAENAS HEMOCYANIN 93
A Novel Prion Protein-Tyrosine Hydroxylase Interaction 93
AN X-RAY-ABSORPTION NEAR-EDGE STRUCTURE SPECTROSCOPY STUDY OF METAL COORDINATION IN CO(II)-SUBSTITUTED CARCINUS-MAENAS HEMOCYANIN 92
LRRK2 deficiency impacts ceramide metabolism in brain 91
Effects of Trehalose on Thermodynamic Properties of Alpha-synuclein Revealed through Synchrotron Radiation Circular Dichroism. 90
Ceftriaxone blocks the polymerization of α-synuclein and exerts neuroprotective effects in vitro. 90
The oxidation of hemocyanin: kinetics, reaction mechanism and characterization of the met-hemocyanin product 89
Impaired dopamine metabolism in Parkinson's disease pathogenesis 88
Structure, spectroscopy, and function of tyrosinase; comparison with hemocyanin and catechol oxidase 87
Biophysical groundwork as a hinge to unravel the biology of α-synuclein aggregation and toxicity. 87
Impact of Biofisics to Phylogeny. 86
Mechanistic Insight into the Activity of Tyrosinase from Variable-Temperature Studies in an Aqueous/Organic Solvent. 86
COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside 86
Synthesis and structural characterization of soluble neuromelanin analogs provides important clues to its biosynthesis. 85
Alpha-synuclein pore forming activity upon membrane association 85
Worm-like ising model for protein mechanical unfolding under the effect of osmolytes. 84
GTPase activity regulates kinase activity and cellular phenotypes of Parkinson's disease-associated LRRK2 84
Entrapment and characterization of functional allosteric conformers of hemocyanin in sol–gel matrices 84
Cobalt substituted derivative of Carcinous hemocyanin 83
α-Synuclein is a Novel Microtubule Dynamase 83
Cross-talk between LRRK2 and PKA: Implication for Parkinson's disease? 83
Quaternary structure and functional properties of Penaeus monodon hemocyanin 83
Investigation of the solid and solution structures of N-substituted Cu(II) salicyldimines by x-ray absorption spectroscopy 83
LOW-TEMPERATURE OPTICAL SPECTROSCOPY OF COBALT-SUBSTITUTED HEMOCYANIN FROM CARCINUS-MAENAS 82
Lysines, Achilles' heel in alpha-synuclein conversion to a deadly neuronal endotoxin 82
Investigation of Streptomyces antibioticus tyrosinase reactivity toward chlorophenols. 82
X-ray absorption analysis of the active site of Streptomyces antibioticus Tyrosinase upon binding of transition state analogue inhibitors 82
Structural characterization of a high affinity mononuclear site in the Copper(II)-alpha-Synuclein complex. 81
The binding of Cd(II) to the hemocyanin of the Mediterranean Crab Carcinus maenas 80
Single-molecule force spectroscopy of chimeric polyprotein constructs containing intrinsically disordered domains 79
Superoxide dismutating molecules rescue the toxic effects of PINK1 and parkin loss. 79
New aspects of the reactivity of tyrosinase. 78
NADH fluorescence lifetime is an endogenous reporter of α-synuclein aggregation in live cells. 78
Structure and topology of the non-amyloid-beta component fragment of human alpha-synuclein bound to micelles: implications for the aggregation process. 78
Unsymmetrical Binding Modes of the HOPNO Inhibitor of Tyrosinase: From Model Complexes to the Enzyme. 77
PAK6 Phosphorylates 14-3-3γ to Regulate Steady State Phosphorylation of LRRK2 76
Saccharose solid matrix embedded proteins:a new method for sample preparation for X-ray absorption spectroscopy 76
The binnding of azide to copper-containing and cobalt-containing forms of hemocyanin from the mediterranean crab Carcinus aestuarii 75
Totale 10.139
Categoria #
all - tutte 56.165
article - articoli 53.404
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 264
selected - selezionate 0
volume - volumi 1.523
Totale 111.356


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.339 0 0 45 264 301 234 264 365 298 279 173 116
2020/20212.337 72 136 58 358 166 124 34 230 294 345 341 179
2021/20222.616 74 289 384 200 123 119 108 340 133 56 275 515
2022/20232.163 427 268 38 312 295 251 5 163 262 22 85 35
2023/2024948 53 133 113 76 83 56 73 52 36 53 133 87
2024/2025348 34 301 13 0 0 0 0 0 0 0 0 0
Totale 14.893